Literature DB >> 18845533

Recombinant collagen studies link the severe conformational changes induced by osteogenesis imperfecta mutations to the disruption of a set of interchain salt bridges.

Ke Xu1, Iwona Nowak, Michele Kirchner, Yujia Xu.   

Abstract

The clinical severity of Osteogenesis Imperfecta (OI), also known as the brittle bone disease, relates to the extent of conformational changes in the collagen triple helix induced by Gly substitution mutations. The lingering question is why Gly substitutions at different locations of collagen cause different disruptions of the triple helix. Here, we describe markedly different conformational changes of the triple helix induced by two Gly substitution mutations placed only 12 residues apart. The effects of the Gly substitutions were characterized using a recombinant collagen fragment modeling the 63-residue segment of the alpha1 chain of type I collagen containing no Hyp (residues 877-939) obtained from Escherichia coli. Two Gly --> Ser substitutions at Gly-901 and Gly-913 associated with, respectively, mild and severe OI variants were introduced by site-directed mutagenesis. Biophysical characterization and limited protease digestion experiments revealed that while the substitution at Gly-901 causes relatively minor destabilization of the triple helix, the substitution at Gly-913 induces large scale unfolding of an unstable region C-terminal to the mutation site. This extensive unfolding is caused by the intrinsic low stability of the C-terminal region of the helix and the mutation induced disruption of a set of salt bridges, which functions to lock this unstable region into the triple helical conformation. The extensive conformational changes associated with the loss of the salt bridges highlight the long range impact of the local interactions of triple helix and suggest a new mechanism by which OI mutations cause severe conformational damages in collagen.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845533      PMCID: PMC2590706          DOI: 10.1074/jbc.M805485200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Cooperative equilibrium transitions coupled with a slow annealing step explain the sharpness and hysteresis of collagen folding.

Authors:  J Engel; H P Bächinger
Journal:  Matrix Biol       Date:  2000-07       Impact factor: 11.583

2.  Type I collagen is thermally unstable at body temperature.

Authors:  E Leikina; M V Mertts; N Kuznetsova; S Leikin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Stabilization of short collagen-like triple helices by protein engineering.

Authors:  S Frank; R A Kammerer; D Mechling; T Schulthess; R Landwehr; J Bann; Y Guo; A Lustig; H P Bächinger; J Engel
Journal:  J Mol Biol       Date:  2001-05-18       Impact factor: 5.469

4.  Characterization of the nucleation step and folding of a collagen triple-helix peptide.

Authors:  Yujia Xu; Manjiri Bhate; Barbara Brodsky
Journal:  Biochemistry       Date:  2002-06-25       Impact factor: 3.162

5.  Single-chain triple helical structure.

Authors:  G N Ramachandran; B B Doyle; E R Blout
Journal:  Biopolymers       Date:  1968       Impact factor: 2.505

6.  Peptide investigations of pairwise interactions in the collagen triple-helix.

Authors:  Anton V Persikov; John A M Ramshaw; Alan Kirkpatrick; Barbara Brodsky
Journal:  J Mol Biol       Date:  2002-02-15       Impact factor: 5.469

7.  Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen.

Authors:  Gloria A Di Lullo; Shawn M Sweeney; Jarmo Korkko; Leena Ala-Kokko; James D San Antonio
Journal:  J Biol Chem       Date:  2001-11-09       Impact factor: 5.157

Review 8.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

Authors:  Joan C Marini; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; James D San Antonio; Sarah Milgrom; James C Hyland; Jarmo Körkkö; Darwin J Prockop; Anne De Paepe; Paul Coucke; Sofie Symoens; Francis H Glorieux; Peter J Roughley; Alan M Lund; Kaija Kuurila-Svahn; Heini Hartikka; Daniel H Cohn; Deborah Krakow; Monica Mottes; Ulrike Schwarze; Diana Chen; Kathleen Yang; Christine Kuslich; James Troendle; Raymond Dalgleish; Peter H Byers
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

9.  Structural heterogeneity of type I collagen triple helix and its role in osteogenesis imperfecta.

Authors:  Elena Makareeva; Edward L Mertz; Natalia V Kuznetsova; Mary B Sutter; Angela M DeRidder; Wayne A Cabral; Aileen M Barnes; Daniel J McBride; Joan C Marini; Sergey Leikin
Journal:  J Biol Chem       Date:  2007-12-11       Impact factor: 5.157

10.  Mechanism of stabilization of a bacterial collagen triple helix in the absence of hydroxyproline.

Authors:  Angela Mohs; Teresita Silva; Takeshi Yoshida; Ravish Amin; Slawomir Lukomski; Masayori Inouye; Barbara Brodsky
Journal:  J Biol Chem       Date:  2007-08-10       Impact factor: 5.157

View more
  14 in total

1.  CD and NMR investigation of collagen peptides mimicking a pathological Gly-Ser mutation and a natural interruption in a similar highly charged sequence context.

Authors:  Xiuxia Sun; Songqing Liu; Wenyuan Yu; Shaoru Wang; Jianxi Xiao
Journal:  Protein Sci       Date:  2015-11-26       Impact factor: 6.725

2.  Dominant-negative effects of COL7A1 mutations can be rescued by controlled overexpression of normal collagen VII.

Authors:  Anja Fritsch; Sashko Spassov; Susanne Elfert; Andreas Schlosser; Yannick Gache; Guerrino Meneguzzi; Leena Bruckner-Tuderman
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

3.  The self-assembly of a mini-fibril with axial periodicity from a designed collagen-mimetic triple helix.

Authors:  Parminder Jeet Kaur; Rebecca Strawn; Hanying Bai; Ke Xu; Gabriel Ordas; Hiroshi Matsui; Yujia Xu
Journal:  J Biol Chem       Date:  2015-02-11       Impact factor: 5.157

4.  Osteogenesis imperfecta missense mutations in collagen: structural consequences of a glycine to alanine replacement at a highly charged site.

Authors:  Jianxi Xiao; Haiming Cheng; Teresita Silva; Jean Baum; Barbara Brodsky
Journal:  Biochemistry       Date:  2011-11-22       Impact factor: 3.162

5.  Osteogenesis imperfecta model peptides: incorporation of residues replacing Gly within a triple helix achieved by renucleation and local flexibility.

Authors:  Jianxi Xiao; Balaraman Madhan; Yingjie Li; Barbara Brodsky; Jean Baum
Journal:  Biophys J       Date:  2011-07-20       Impact factor: 4.033

6.  Three-dimensional directed self-assembly of Peptide nanowires into micrometer-sized crystalline cubes with nanoparticle joints.

Authors:  Prerna Kaur; Yoshiaki Maeda; Andrew C Mutter; Tadashi Matsunaga; Yujia Xu; Hiroshi Matsui
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-02       Impact factor: 15.336

7.  Sequence environment of mutation affects stability and folding in collagen model peptides of osteogenesis imperfecta.

Authors:  Michael A Bryan; Haiming Cheng; Barbara Brodsky
Journal:  Biopolymers       Date:  2011       Impact factor: 2.505

8.  Local amino acid sequence patterns dominate the heterogeneous phenotype for the collagen connective tissue disease Osteogenesis Imperfecta resulting from Gly mutations.

Authors:  Jianxi Xiao; Zhangfu Yang; Xiuxia Sun; Rayna Addabbo; Jean Baum
Journal:  J Struct Biol       Date:  2015-05-15       Impact factor: 2.867

9.  NMR conformational and dynamic consequences of a gly to ser substitution in an osteogenesis imperfecta collagen model peptide.

Authors:  Yingjie Li; Barbara Brodsky; Jean Baum
Journal:  J Biol Chem       Date:  2009-05-18       Impact factor: 5.157

10.  Molecular underpinnings of integrin binding to collagen-mimetic peptides containing vascular Ehlers-Danlos syndrome-associated substitutions.

Authors:  Cody L Hoop; Allysa P Kemraj; Baifan Wang; Sonal Gahlawat; Madison Godesky; Jie Zhu; Haley R Warren; David A Case; David I Shreiber; Jean Baum
Journal:  J Biol Chem       Date:  2019-08-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.